United States securities and exchange commission logo

                           August 8, 2023

       Michael Richman
       Chief Executive Officer
       NextCure, Inc.
       9000 Virginia Manor Road, Suite 200
       Beltsville, Maryland 20705

                                                        Re: NextCure, Inc.
Statement on Form S-3
                                                            Filed August 4,
                                                            File No. 333-273723

       Dear Michael Richman:

              This is to advise you that we have not reviewed and will not
review your registration

               Please refer to Rules 460 and 461 regarding requests for
acceleration. We remind you
       that the company and its management are responsible for the accuracy and
adequacy of their
       disclosures, notwithstanding any review, comments, action or absence of
action by the staff.

                                                        Please contact Dillon
Hagius at 202-551-7967 with any questions.


                           Division of Corporation Finance

                           Office of Life Sciences
       cc:                                              Kostian Ciko